MUC1*-ANTIKÖRPER

European patent · EP3130607 · In force

Register entry

Publication number
EP3130607
Application number
EP16190400
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Oct 6, 2009
Published
Feb 15, 2017
Granted
Apr 17, 2024
Protection ends at the latest
Oct 5, 2029
Next annual fee due
Oct 31, 2026
IPC classes
C07K 16/30 (2006.01)
C12P 21/08 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
Priority
US 103204 P 06.10.2008
Divided from
EP09819788
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Nov 1, 2025

    Change

    Published in Swissreg on 01.11.2025

  2. Feb 26, 2025

    Change

    Published in Swissreg on 26.02.2025

  3. Nov 1, 2024

    Change

    Published in Swissreg on 01.11.2024

  4. Jun 27, 2024

    Agent entered

    Representative
    MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex

    Published in Swissreg on 27.06.2024

  5. Apr 17, 2024

    Granted

    Published in Swissreg on 17.04.2024

Parties

Holder

Minerva Biotechnologies Corporation

40 Bear Hill Rd., Waltham, MA 02451, US

Agent

MICHELI & CIE SA

122, rue de Genève, CP 61, 1226 Thônex

Inventor

MAHANTA, Sanjeev

Southborough, MA 01772, US

BAMDAD, Cynthia

Boston, MA 02115, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.